|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross Profit | |||||
| Operating Expenses | |||||
| General and administrative | |||||
| Professional fees | |||||
| Sales and marketing | |||||
| Amortization and depreciation | |||||
| Research and development | |||||
| Total operating expense | |||||
| Operating loss | |||||
| Other income (expense) | |||||
| Other income | |||||
| Interest income | |||||
| Impairment of intangible asset | |||||
| Foreign currency transaction loss | |||||
| Interest expense | |||||
| Disposal of assets | |||||
| Gain on change in fair value of warrant derivative liability | |||||
| Loss on derivative issuance | |||||
| Gain on change in fair value of derivative liabilities | |||||
| Foreign currency transaction gain | |||||
| Total other income (expense) | |||||
| Net loss before income tax | |||||
| Net loss after income tax | |||||
| Foreign currency translation gain | |||||
| Foreign currency translation (loss) gain | |||||
| Total other comprehensive income (loss) | |||||
| Net comprehensive loss | |||||
| Net loss per common share, basic | |||||
| Net loss per common share, diluted | |||||
| Weighted average number of common shares outstanding, basic | |||||
| Weighted average number of common shares outstanding, diluted | |||||
Loading...